ArticleThe Journal of organic chemistry2020
Open access · hybridAbstract read
In one paragraph
Article in The Journal of organic chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 23 citations in OpenAlex.
- Exploration of the aromatic abietane diterpenoid scaffold in the development of ArnT-mediated colistin resistance inhibitors.RSC advances · 2026Article
- Natural compounds: a promising therapeutic option for managing colistin-resistant bacteria and improving colistin activity.Molecular biology reports · 2026Review
- Polymyxin resistance in Gram-negative bacteria: a comprehensive review with a focus on the role of 4-amino-4-doexy-L-arabinose.Molecular biology reports · 2025Review
- Biological Evaluation and Computational Modelling Studies onCurrent pharmaceutical design · 2025Article
- Advances in Development of Novel Therapeutic Strategies against Multi-Drug ResistantAntibiotics (Basel, Switzerland) · 2024Review
- Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity.ACS omega · 2023Article
- Untying the anchor for the lipopolysaccharide: lipid A structural modification systems offer diagnostic and therapeutic options to tackle polymyxin resistance.Arhiv za higijenu rada i toksikologiju · 2023Review
- Regulatory Landscape of theAntibiotics (Basel, Switzerland) · 2023Article
- Biologically Active Diterpenoids in theInternational journal of molecular sciences · 2022Review
- Diterpenoid Constituents ofJournal of natural products · 2022Review
- The Triprenylated Anthranoid Ferruginin A, a Promising Scaffold for the Development of Novel Antibiotics against Gram-Positive Bacteria.Antibiotics (Basel, Switzerland) · 2022Article
- Benzimidazole Isosteres of Salicylanilides Are Highly Active Colistin Adjuvants.ACS infectious diseases · 2021Article
- How to Combat Gram-Negative Bacteria Using Antimicrobial Peptides: A Challenge or an Unattainable Goal?Antibiotics (Basel, Switzerland) · 2021Review
- Identification of Effective Anticancer G-Quadruplex-Targeting Chemotypes through the Exploration of a High Diversity Library of Natural Compounds.Pharmaceutics · 2021Article
- Antibiotic Adjuvant Activity Revealed in a Photoaffinity Approach to Determine the Molecular Target of Antipyocyanin Compounds.ACS infectious diseases · 2021Article
- Exogenous and Endogenous Phosphoethanolamine Transferases Differently Affect Colistin Resistance and Fitness inFrontiers in microbiology · 2021Article
- Antimicrobial Diterpenes: Recent Development From Natural Sources.Frontiers in pharmacology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 6 institutions in 2 countries.
Deborah QuaglioDepartment of Chemistry and Technology of Drugs, "Department of Excellence 2018-2022", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
Maria Luisa MangoniLaboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0002-5991-5868
Roberta StefanelliDepartment of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Via dei Sardi 70, 00185 Rome, Italy.
Silvia CorradiDepartment of Chemistry and Technology of Drugs, "Department of Excellence 2018-2022", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
Bruno CasciaroCenter for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161 Rome, Italy.
Valeria VergineDepartment of Chemistry and Technology of Drugs, "Department of Excellence 2018-2022", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
Federica LucantoniDepartment of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Via dei Sardi 70, 00185 Rome, Italy.
Luca CavinatoDepartment of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Via dei Sardi 70, 00185 Rome, Italy.
Silvia CammaroneDepartment of Chemistry and Technology of Drugs, "Department of Excellence 2018-2022", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
Maria Rosa LoffredoLaboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
Floriana CappielloLaboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
Andrea CalcaterraDepartment of Chemistry and Technology of Drugs, "Department of Excellence 2018-2022", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
Silvia ErazoDepartment of Pharmacological and Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, 1058 Santiago, Chile.
Francesca GhirgaCenter for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161 Rome, Italy.ORCID 0000-0002-5591-5190
Mattia MoriDepartment of Biotechnology, Chemistry and Pharmacy, "Department of Excellence 2018-2022", University of Siena, via Aldo Moro 2, 53100 Siena, Italy.ORCID 0000-0003-2398-1254
Francesco ImperiDepartment of Science, Roma Tre University, Viale Guglielmo Marconi 446, 00146 Rome, Italy.
Fiorentina AscenzioniDepartment of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Via dei Sardi 70, 00185 Rome, Italy.
Bruno BottaDepartment of Chemistry and Technology of Drugs, "Department of Excellence 2018-2022", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0001-8707-4333
Istituto Pasteur · ITSapienza University of Rome · ITItalian Institute of Technology · ITRoma Tre University · ITUniversity of Chile · CLUniversity of Siena · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colistin is a last-resort antibiotic for the treatment of multidrug resistant Gram-negative bacterial infections. Recently, a natural
Indexed as
ColistinDiterpenesAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialMicrobial Sensitivity TestsPseudomonas aeruginosaAnti-Bacterial AgentsBacterial ProteinsColistinDiterpenes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.